Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/981417766
总结
Allele T is associated with decreased progression-free survival (PFS) time when treated with erlotinib or gefitinib in people with EGFR mutation positive non-small-cell lung cancer as compared to allele C.